Cambridge Investment Research Advisors Inc. raised its stake in Equifax, Inc. (NYSE:EFX) by 34.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,675 shares of the credit services provider’s stock after buying an additional 1,727 shares during the period. Cambridge Investment Research Advisors Inc.’s holdings in Equifax were worth $913,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of EFX. Cipher Capital LP acquired a new position in Equifax during the fourth quarter valued at $753,000. Van ECK Associates Corp raised its position in Equifax by 7.7% in the fourth quarter. Van ECK Associates Corp now owns 1,522 shares of the credit services provider’s stock valued at $180,000 after buying an additional 109 shares during the period. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its position in Equifax by 0.7% in the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 6,865 shares of the credit services provider’s stock valued at $812,000 after buying an additional 49 shares during the period. Private Advisor Group LLC raised its position in Equifax by 4.5% in the fourth quarter. Private Advisor Group LLC now owns 1,918 shares of the credit services provider’s stock valued at $231,000 after buying an additional 82 shares during the period. Finally, Tredje AP fonden raised its position in Equifax by 21.7% in the fourth quarter. Tredje AP fonden now owns 5,453 shares of the credit services provider’s stock valued at $645,000 after buying an additional 973 shares during the period. 89.96% of the stock is owned by hedge funds and other institutional investors.

Institutional Ownership by Quarter for Equifax (NYSE:EFX)

Equifax, Inc. (EFX) traded down 0.54% during trading on Wednesday, reaching $138.80. The company’s stock had a trading volume of 203,161 shares. The firm has a market cap of $16.69 billion, a PE ratio of 31.19 and a beta of 0.89. The company has a 50-day moving average of $137.33 and a 200 day moving average of $129.78. Equifax, Inc. has a one year low of $110.87 and a one year high of $144.01.

Equifax (NYSE:EFX) last announced its earnings results on Wednesday, April 26th. The credit services provider reported $1.44 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.41 by $0.03. Equifax had a net margin of 16.62% and a return on equity of 25.20%. The business had revenue of $832.20 million during the quarter, compared to the consensus estimate of $825.14 million. During the same quarter last year, the firm earned $1.23 earnings per share. The business’s revenue for the quarter was up 14.3% on a year-over-year basis. Analysts expect that Equifax, Inc. will post $6.06 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 15th. Shareholders of record on Thursday, May 25th were paid a dividend of $0.39 per share. This represents a $1.56 dividend on an annualized basis and a dividend yield of 1.12%. The ex-dividend date of this dividend was Tuesday, May 23rd. Equifax’s dividend payout ratio is 35.14%.

WARNING: “Equifax, Inc. (EFX) Position Boosted by Cambridge Investment Research Advisors Inc.” was reported by Daily Political and is owned by of Daily Political. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2017/06/21/equifax-inc-efx-position-boosted-by-cambridge-investment-research-advisors-inc.html.

EFX has been the subject of several research analyst reports. Stifel Nicolaus lifted their price objective on Equifax from $144.00 to $149.00 and gave the stock a “buy” rating in a research report on Wednesday, March 22nd. Atlantic Securities initiated coverage on Equifax in a research report on Thursday, March 23rd. They issued an “overweight” rating and a $156.00 price objective for the company. Royal Bank Of Canada reissued a “buy” rating and issued a $144.00 price objective on shares of Equifax in a research report on Thursday, March 30th. Stephens lowered Equifax from an “overweight” rating to an “equal weight” rating in a research report on Friday, April 28th. Finally, Argus assumed coverage on Equifax in a research report on Tuesday, June 13th. They issued a “buy” rating and a $166.00 price objective for the company. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and nine have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $141.50.

In other Equifax news, CFO John W. Gamble, Jr. sold 14,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 23rd. The shares were sold at an average price of $136.44, for a total transaction of $1,910,160.00. Following the completion of the transaction, the chief financial officer now owns 48,578 shares of the company’s stock, valued at $6,627,982.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.29% of the stock is currently owned by company insiders.

Equifax Company Profile

Equifax Inc is a global provider of information solutions and human resources business process outsourcing services for businesses, governments and consumers. The Company operates in four segments: U.S. Information Solutions (USIS), International, Workforce Solutions and Global Consumer Solutions. Its products and services are based on databases of consumer and business information derived from various sources, including credit, financial assets, telecommunications and utility payments, employment, income, demographic and marketing data.

Want to see what other hedge funds are holding EFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Equifax, Inc. (NYSE:EFX).

Receive News & Ratings for Equifax Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Equifax Inc. and related companies with MarketBeat.com's FREE daily email newsletter.